HIV-1 Vpr increases HCV replication through VprBP in cell culture.
Coinfection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) occurs at a high frequency, in which HIV shows a promotion of HCV-derived liver diseases. However, the mechanism of how this occurs is not well understood. Our previous work has demonstrated that the HIV-1 accessory protein Vpr enhances HCV ... RNA replication in cell culture. Because Vpr performs most of its functions through host protein VprBP (DCAF1), the role of VprBP in the regulation of HCV by Vpr was investigated in this study. We found that the Vpr mutant Q65R, which is deficient in VprBP binding, could not enhance HCV replication. Furthermore, Vpr-mediated enhancement of HCV replication was severely diminished in VprBP knockdown cells. In addition, an inhibitor of Cullin RING E3 ligases, MLN4924, impaired the function of Vpr during HCV replication. Together, these results suggest that Vpr promotes HCV replication in a VprBP-dependent manner, and that the activity of Cullin RING E3 ligases is essential to this process. In conclusion, our findings demonstrate that HIV-1 Vpr makes the cellular environment more suitable for HCV replication, which might relate with the host ubiquitination system.
Mesh Terms:
Carrier Proteins, Cell Line, Cells, Cultured, Coinfection, Gene Knockdown Techniques, Genome, Viral, HIV Infections, HIV-1, Hepacivirus, Hepatitis C, Humans, Microbial Interactions, Mutation, Protein Binding, RNA, Viral, Virus Replication, vpr Gene Products, Human Immunodeficiency Virus
Carrier Proteins, Cell Line, Cells, Cultured, Coinfection, Gene Knockdown Techniques, Genome, Viral, HIV Infections, HIV-1, Hepacivirus, Hepatitis C, Humans, Microbial Interactions, Mutation, Protein Binding, RNA, Viral, Virus Replication, vpr Gene Products, Human Immunodeficiency Virus
Virus Res.
Date: Dec. 02, 2015
PubMed ID: 27460548
View in: Pubmed Google Scholar
Download Curated Data For This Publication
208166
Switch View:
- Interactions 1